Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial.

Cohen C, Nieto-Cisneros L, Zala C, Fessel WJ, Gonzalez-Garcia J, Gladysz A, McGovern R, Adler E, McLaren C; BMS AI424-043 Study Group.

Curr Med Res Opin. 2005 Oct;21(10):1683-92.

PMID:
16238909
3.

[Efficacy of atazanavir in treatment-naive patients].

Moreno S, Hernández B, Dronda F.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:9-13. doi: 10.1016/S0213-005X(08)76614-X. Review. Spanish.

PMID:
20116611
4.

Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.

Cahn PE, Gatell JM, Squires K, Percival LD, Piliero PJ, Sanne IA, Shelton S, Lazzarin A, Odeshoo L, Kelleher TD, Thiry A, Giordano MD, Schnittman SM.

J Int Assoc Physicians AIDS Care (Chic). 2004 Jul-Sep;3(3):92-8. Review.

PMID:
15573713
5.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Oldfield V, Plosker GL.

Drugs. 2006;66(9):1275-99. Review.

PMID:
16827606
6.

The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.

Chetchotisakd P.

Expert Rev Anti Infect Ther. 2009 Sep;7(7):801-5. doi: 10.1586/eri.09.66. Review.

PMID:
19735222
7.

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.

Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA.

AIDS. 2009 Jan 28;23(3):279-91. doi: 10.1097/QAD.0b013e32831c54e5. Review.

PMID:
19114854
8.

Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials.

Carey D, Amin J, Boyd M, Petoumenos K, Emery S.

J Antimicrob Chemother. 2010 Sep;65(9):1878-88. doi: 10.1093/jac/dkq231. Epub 2010 Jun 16. Review.

PMID:
20554568
9.
10.

[Efficacy of atazanavir in simplification regimens].

Zamora L, Gatell JM.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:14-21. doi: 10.1016/S0213-005X(08)76615-1. Review. Spanish.

PMID:
20116612
11.

Atazanavir: a new protease inhibitor to treat HIV infection.

Musial BL, Chojnacki JK, Coleman CI.

Am J Health Syst Pharm. 2004 Jul 1;61(13):1365-74. Review. Erratum in: Am J Health Syst Pharm. 2004 Nov 1;61(21):2243.

PMID:
15287232
13.

Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a review.

Gianotti N, Soria A, Lazzarin A.

New Microbiol. 2007 Apr;30(2):79-88. Review.

14.

Atazanavir: in pediatric patients with HIV-1 infection.

Deeks ED.

Paediatr Drugs. 2012 Apr 1;14(2):131-41. doi: 10.2165/11208550-000000000-00000. Review.

PMID:
22292486
15.

[Clinical utility of atazanavir].

Ribera Pascuet E, Curran A.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:55-67. doi: 10.1016/S0213-005X(08)76622-9. Review. Spanish.

PMID:
20116619
16.

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection.

Kaplan SS, Hicks CB.

Expert Opin Pharmacother. 2005 Aug;6(9):1573-85. Review.

PMID:
16086645
17.

Clinical pharmacology, efficacy and safety of atazanavir: a review.

Bentué-Ferrer D, Arvieux C, Tribut O, Ruffault A, Bellissant E.

Expert Opin Drug Metab Toxicol. 2009 Nov;5(11):1455-68. doi: 10.1517/17425250903321514. Review.

PMID:
19863454
18.

Atazanavir: new option for treatment of HIV infection.

Havlir DV, O'Marro SD.

Clin Infect Dis. 2004 Jun 1;38(11):1599-604. Epub 2004 May 13. Review.

PMID:
15156449
19.

[Efficacy of atazanavir in rescue therapy].

Portilla J, Boix V, Merino E, Reus S.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:22-7. doi: 10.1016/S0213-005X(08)76616-3. Review. Spanish.

PMID:
20116613
20.

Initiation of antiretroviral therapy: implications of recent findings.

Saag MS.

Top HIV Med. 2004 Jul-Aug;12(3):83-8. Review.

Supplemental Content

Support Center